Congress Resource Centre
Global Edition Home
Contact us
Up to the minute coverage from key international congresses
Offering the latest congress news in oncology !
DG Dispatch
your speedy delivery of the latest news and highlights direct from medical congresses ...
keeping you medically current !
DG Dispatches - Oncology
12/16/2009
Ketorolac Tromethamine Does Not Reduce Pain, Discomfort Associated With Mammograms: Presented at SABCS
12/15/2009
Anthracycline-Docetaxel Chemo as Effective, but Less Toxic Than Anthracycline Polychemotherapy for Breast Cancer: Presented at SABCS
12/15/2009
Zoledronic Acid Improves Bone Loss Associated With Adjuvant AI Therapy in Postmenopausal Breast Cancer Patients: Presented at SABCS
12/15/2009
Benefits of Docetaxel After FEC Regimen Sustained for 8 Years in Node-Positive Breast Cancer: Presented at SABCS
12/15/2009
Letrozole/Trastuzumab Superior to Letrozole Alone for Patients With Both HR+, HER2+ Metastatic Breast Cancer: Presented at SABCS
12/14/2009
Exemestane Therapy Show Unfavourable Changes in Lipid Profile: Presented at SABCS
12/14/2009
Bevacizumab Plus Docetaxel Improves Progression-Free Survival, but Not Overall Survival in Metastatic Breast Cancer: Presented at SABCS
12/14/2009
Adding Bevacizumab to Second-Line Chemo Improves Progression-Free Survival in Metastatic Breast Cancer: Presented at SABCS
12/14/2009
Switching to an Aromatase Inhibitor at Year 5 of Tamoxifen Therapy Reduces Breast Cancer Recurrence: Presented at SABCS
12/14/2009
Primary Tumour Resection Improves Outcomes in Advanced Breast Cancer: Presented at SABCS
12/13/2009
ACE Inhibitors and ARBs May Protect Against Breast Cancer Recurrence: Presented at SABCS
12/13/2009
Neratinib/Paclitaxel Combination Shows Promise in Metastatic Breast Cancer: Presented at SABCS
12/13/2009
Long-Term Follow-Up Using PET-CT Can Help Detect Lymph Node Recurrence in Breast Cancer: Presented at SABCS
12/13/2009
Adjuvant Trastuzumab With Chemotherapy for 1 Year Delays Breast Cancer Progression: Presented at SABCS
12/12/2009
Whole Radiation Recommended for Mucinous Carcinoma: Presented at SABCS
12/12/2009
Docetaxel Plus Capecitabine Shows More Benefit as First-Line Therapy for Metastatic Breast Cancer Than Docetaxel Plus Epirubicin: Presented at SABCS
12/12/2009
No Survival Benefit for 5-FU/Docetaxel After Preoperative Epirubicin/Cyclophosphamide in Inflammatory Breast Cancer: Presented at SABCS
12/12/2009
Adding Bevacizumab to Second-Line Chemo Improves Progression-Free Survival in Metastatic Breast Cancer: Presented at SABCS
12/12/2009
Risks of Autologous Stem-Cell Transplantation Outweigh Benefits in Treating High-Risk Breast Cancer: Presented at SABCS
12/12/2009
Adding Lapatinib, Continuing Trastuzumab Despite Progression Adds Months to Breast Cancer Survival: Presented at SABCS
12/11/2009
Ibandronate Offers Pain Relief With Renal Safety in Women With Breast Cancer, Metastatic Bone Disease: Presented at SABCS
12/11/2009
Exemestane for 5 Years Not Superior to Tamoxifen Followed by Exemestane for Breast Cancer: Presented at SABCS
12/11/2009
No Cardiac Safety Problems When Casopitant Is Given With Anthracycline for Malignant Solid Tumours: Presented at SABCS
12/11/2009
High-Dose Fulvestrant Postpones Disease Progression in Advanced Breast Cancer: Presented at SABCS
12/11/2009
Lymphedema Continues to Appear Years After Breast Cancer Treatment: Presented at SABCS
12/11/2009
Pregnancy Does Not Worsen Outcomes Among Women With Breast Cancer: Presented at SABCS
12/11/2009
Optimal Duration of Neoadjuvant Letrozole Longer Than the Traditional 4 Months to Permit Breast-Conserving Surgery: Presented at SABCS
12/11/2009
Letrozole Superior to Tamoxifen in Hormone Receptor-Positive Early Breast Cancer: Presented at SABCS
12/11/2009
Febrile Neutropenia Occurs More Frequently in Real World Setting Than in Clinical Trials: Presented at SABCS
12/11/2009
Lapatinib Plus Nab-Paclitaxel Shows Promise for HER2-Positive Breast Cancer: Presented at SABCS
All contents Copyright (c) 2002 P\S\L Consulting Group Inc. All rights reserved.